TNFRSF1B and ovarian carcinoma: This is particularly important in the case of TNFR2+ Teffs, since our studies show that, similarly to what has been demonstrated in autoimmunity (84), that these cells may only be suppressed by TNFR2+ Tregs within ovarian cancer ascites.